AbbVie (ABBV) Price to Earnings (2013 - 2026)
AbbVie's (ABBV) Price to Earnings came in at 44.74 for Q3 2026, down 73.9% from 171.37 a year earlier and down 36.5% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Price to Earnings (2013 - 2026) Analysis & Trends
For FY2025, AbbVie's Price to Earnings stood at 95.60, up 30.4% from FY2024.
- Annual Price to Earnings has increased for four consecutive years.
- In prior years, AbbVie's Price to Earnings was 73.33 in FY2024 (+30.3%), 56.29 in FY2023 (+133.0%), 24.16 in FY2022 (+16.4%) and 20.75 in FY2021 (-49.4%).
- The Q3 2026 figure stands as the lowest quarterly Price to Earnings since Q3 2023.
- On a year-over-year basis, Price to Earnings increased in six of the last eight quarters, with growth averaging 32.1%.
- The strongest year-over-year quarter for Price to Earnings in the past five years was Q3 2025, with growth of 151.5%; the weakest was Q3 2026, with a decline of 73.9%.
- According to Business Quant data, Price to Earnings for the three prior quarters was 70.47 (Q2 2026), 105.71 (Q1 2026) and 95.60 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 44.74 |
| Jun 30, 2026 | 70.47 |
| Mar 31, 2026 | 105.71 |
| Dec 31, 2025 | 95.60 |
| Sep 30, 2025 | 171.37 |
| Jun 30, 2025 | 87.14 |
| Mar 31, 2025 | 88.22 |
| Dec 31, 2024 | 73.33 |
| Sep 30, 2024 | 68.13 |
| Jun 30, 2024 | 56.75 |
| Mar 31, 2024 | 53.66 |
| Dec 31, 2023 | 56.29 |
| Sep 30, 2023 | 40.40 |
| Jun 30, 2023 | 27.38 |
| Mar 31, 2023 | 37.07 |
| Dec 31, 2022 | 24.16 |
| Sep 30, 2022 | 17.70 |
| Jun 30, 2022 | 21.43 |
| Mar 31, 2022 | 22.96 |
| Dec 31, 2021 | 20.75 |
API Access
AbbVie Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();